Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?

被引:1
|
作者
Gabriel Tayguara Silveira Guerreiro
Larisse Longo
Mariana Alves Fonseca
Valessa Emanoele Gabriel de Souza
Mário Reis Álvares-da-Silva
机构
[1] Universidade Federal Do Rio Grande Do Sul (UFRGS),Graduate Program in Gastroenterology and Hepatology
[2] Hospital de Clínicas de Porto Alegre,Experimental Laboratory of Hepatology and Gastroenterology, Center for Experimental Research
[3] Hospital de Clínicas de Porto Alegre,Division of Gastroenterology
来源
Hepatology International | 2021年 / 15卷
关键词
ASCVD risk estimator; Atherogenic ratios; Cardiovascular diseases; Cardiovascular risk; Inflammatory activity; Metabolic-associated fatty liver disease; Non-alcoholic fatty liver disease; Non-fatal cardiovascular events; Steatosis; Viral infection;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:380 / 391
页数:11
相关论文
共 50 条
  • [1] Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
    Silveira Guerreiro, Gabriel Tayguara
    Longo, Larisse
    Fonseca, Mariana Alves
    Gabriel de Souza, Valessa Emanoele
    Alvares-da-Silva, Mario Reis
    [J]. HEPATOLOGY INTERNATIONAL, 2021, 15 (02) : 380 - 391
  • [2] Predictors of Incident Cardiovascular Disease in Adults with Biopsy-Proven NAFLD
    Henson, Jacqueline
    Simon, Tracey G.
    Kaplan, Aly
    Osganian, Stephanie
    Nath, Cheryl
    Corey, Kathleen E.
    [J]. HEPATOLOGY, 2018, 68 : 972A - 973A
  • [3] ADVANCED FIBROSIS IS ASSOCIATED WITH INCIDENT CARDIOVASCULAR DISEASE IN PATIENTS WITH BIOPSY-PROVEN NAFLD
    Henson, Jacqueline
    Simon, Tracey G.
    Kaplan, Alyson
    Masia, Ricard
    Osganian, Stephanie
    Corey, Kathleen E.
    [J]. HEPATOLOGY, 2019, 70 : 713A - 714A
  • [4] The Performance of the NAFLD Fibrosis Score in Hispanics With Type 2 Diabetes and Biopsy-Proven NAFLD
    Barbara, Mary
    Annunziata, Giuseppe
    Noureddin, Mazen
    Alkhouri, Naim
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S578 - S578
  • [5] Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD
    Zhou, Yu-Jie
    Zheng, Kenneth, I
    Ma, Hong-Lei
    Li, Gang
    Pan, Xiao-Yan
    Zhu, Pei-Wu
    Targher, Giovanni
    Byrne, Christopher D.
    Wang, Xiao-Dong
    Chen, Yong-Ping
    Li, Xiao-Bo
    Zheng, Ming-Hua
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (02) : 552 - 560
  • [6] Cognitive impairment is frequent in obesity and not restricted to persons with biopsy-proven NAFLD
    Wernberg, Charlotte
    Gronkjaer, Lea Ladegaard
    Jacobsen, Birgitte
    Chandran, Vineesh Indira
    Graversen, Jonas
    Krag, Aleksander
    Weissenborn, Karin
    Vilstrup, Hendrik
    Lauridsen, Mette Munk
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S629 - S629
  • [7] Causes of death by fibrosis stage in 959 biopsy-proven NAFLD patients
    Shang, Ying
    Akbari, Camilla
    Dodd, Maja
    Nasr, Patrik
    Vessby, Johan
    Rorsman, Fredrik
    Kechagias, Stergios
    Stal, Per
    Ekstedt, Mattias
    Hagstrom, Hannes
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S605 - S605
  • [8] Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD
    Shang, Ying
    Akbari, Camilla
    Dodd, Maja
    Nasr, Patrik
    Vessby, Johan
    Rorsman, Fredrik
    Kechagias, Stergios
    Stal, Per
    Ekstedt, Mattias
    Hagstrom, Hannes
    [J]. GUT, 2024,
  • [9] Exosomal miRNA analysis for classifying severity of disease in biopsy-proven NAFLD patients
    Lee, Young-Sun
    Chang, Sung Won
    Lee, Ha Seok
    Kim, Sehwa
    Bak, Haein
    Lee, Min-jin
    Jung, Young Kul
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yim, Hyung Joon
    Yeon, Jong Eun
    Um, Soon Ho
    Byun, Kwan Soo
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E777 - E777
  • [10] Change in liver enzyme profile in biopsy-proven NAFLD and NASH in Bariatric patients
    Dimond, Sarah
    Jennings, Neil
    Schroeder, Norbert
    Carr, William
    Mahawar, Kamal
    Small, Peter
    Balupuri, Shlok
    [J]. BRITISH JOURNAL OF SURGERY, 2017, 104 : 20 - 20